Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA-PDT With Different Incubation Times for Actinic Keratosis
NCT03066843Completed
- Sponsor
- Northwestern University
- Start
- Mar 2017
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of 5-aminolevulinic acid in actinic keratosis (AK) (2 arms), sponsored by Northwestern University. Primary endpoint: Change in number of Actinic Keratosis (AK) lesions at 8 weeks. Started Mar 2017; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03066843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03066843.